<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In hypertensive <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, the use of <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> treatment is often delayed because autoregulation of cerebral blood flow (CBF) is often impaired during the first 4 weeks after large <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known as to whether such delay is necessary in cases of small to moderate size <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We compared changes of regional CBF during <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> treatment in <z:hpo ids='HP_0011011'>subacute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> phases of <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Blood pressure was controlled with an <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitor</z:chebi> (n=6) or <z:chebi fb="0" ids="50075">dihydropyridine</z:chebi> calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> (n=8), administered orally for 2 weeks during the <z:hpo ids='HP_0011011'>subacute</z:hpo> (n=7) and <z:hpo ids='HP_0011010'>chronic</z:hpo> phases after (n=7) <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>CBF was measured by the stable <z:chebi fb="3" ids="49957">xenon</z:chebi>-computed tomography (CT) method </plain></SENT>
<SENT sid="5" pm="."><plain>Blood pressure decreased significantly from 132+/-20 mm Hg (mean+/-standard deviation) to 118+/-14 mm Hg (P&lt;.05, paired t-test) in <z:hpo ids='HP_0011011'>subacute</z:hpo> patients and from 135+/-17 mm Hg to 113+/-12 mm Hg (P&lt;.001, paired t-test) in <z:hpo ids='HP_0011010'>chronic</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>There was no significant reduction either in mean hemispheric blood flow or in deep white matter blood flow during each phase </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that mild control of blood pressure among hypertensive patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarctions</z:e> does not produce clinically significant decreases in regional CBF during <z:hpo ids='HP_0011011'>subacute</z:hpo> phases of infarction </plain></SENT>
</text></document>